(2018), the ATR kinase inhibitor AZD6738 combined with radiation therapy boosted infiltration, increased cell proliferation, enhanced IFNγ production by CD8 T cells, and caused a decrease in the number of Tregs and exhausted T cells in the tumor in mouse models. This evidence concerns the gene CD8A and neoplasm.